Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...

Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...

Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

DEAR DR. ROACH: My 86-year-old mother wears hearing aids, has tinnitus and is constantly dizzy. She also has atrial ...

Most of these medications have "dizziness" as a side effect. It is possible that her medications are the cause of her ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

My 86-year-old mother wears hearing aids, has tinnitus and is constantly dizzy. She also has atrial fibrillation, high blood ...

Health officials in US President Donald Trump's administration are reportedly exploring an international reference pricing ...

A late-stage study found Cobenfy wasn’t better than a placebo as an add-on to atypical antipsychotics. Some analysts view the failure as a “significant hit” to the drug’s commercial outlook.

Drug pricing and other pilots are typically ... Top-selling blood thinner Eliquis from Bristol Myers Squibb (BMY.N), opens new tab carries a U.S. list price of $606 for a month's supply.

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...